BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:25 PM
May 11, 2010
 |  BC Extra  |  Company News

Merck discontinues MK-2578

Merck & Co. Inc. (NYSE:MRK) disclosed in a business and R&D update that it discontinued development of MK-2578, a biosimilar pegylated erythropoietin. Merck...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >